Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 1, 2011, Pages 120-128

  Mitra, Mayurranjan S ^a   Schilling, Joel D ^a   Wang, Xiaowei ^a   Jay, Patrick Y ^a   Huss, Janice M ^b   Su, Xiong ^a   Finck, Brian N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Estrogen Related Receptors; Heart failure; Lipin; Metabolism; PGC 1 ; Phosphatidic Acid

Indexed keywords

ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR GAMMA; LIPIN 1; MUSCLE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDIC ACID; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; INTRON; LPIN1 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CLENBUTEROL; DIGLYCERIDES; HEART FAILURE; INTRONS; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

MUS; MUS MUSCULUS;

EID: 79956293920     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.04.009     Document Type: Article

References (43)

1. Huss J.M., Kelly D.P. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 2005, 115:547-555.
2. Rupp H., Zarain-Herzberg A., Maisch B. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz 2002, 27:621-636.
3. Kelly D.P., Strauss A.W. Inherited cardiomyopathies. N Engl J Med 1994, 330:913-919.
4. Peterfy M., Phan J., Xu P., Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 2001, 27:121-124.
5. Peterfy M., Phan J., Oswell G.M., Xu P., Reue K. Genetic, physical, and transcript map of the fld region on mouse chromosome 12. Genomics 1999, 62:436-444.
6. Reue K., Xu P., Wang X.P., Slavin B.G. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res 2000, 41:1067-1076.
7. Donkor J., Sariahmetoglu M., Dewald J., Brindley D.N., Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem 2007, 282:3450-3457.
8. Finck B.N., Gropler M.C., Chen Z., Leone T.C., Croce M.A., Harris T.E., et al. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab 2006, 4:199-210.
9. Kim HB, Kumar A, Wang L, Liu GH, Keller SR, Lawrence JC, Jr, et al. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol Cell Biol 30: 3126-39.
10. Han G.S., Wu W.I., Carman G.M. The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. J Biol Chem 2006, 281:9210-9218.
11. Harris T.E., Huffman T.A., Chi A., Shabanowitz J., Hunt D.F., Kumar A., et al. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J Biol Chem 2007, 282:277-286.
12. Schoonderwoerd K., Broekhoven-Schokker S., Hulsmann W.C., Stam H. Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes. Biochem J 1990, 268:487-492.
13. Jamal Z., Martin A., Gomez-Munoz A., Hales P., Chang E., Russell J.C., et al. Phosphatidate phosphohydrolases in liver, heart and adipose tissue of the JCR:LA corpulent rat and the lean genotypes: implications for glycerolipid synthesis and signal transduction. Int J Obes Relat Metab Disord 1992, 16:789-799.
14. Burgdorf C., Hansel L., Heidbreder M., Johren O., Schutte F., Schunkert H., et al. Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus. Biochem Biophys Res Commun 2009, 390:165-170.
15. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 2005, 3:e101.
16. Russell L.K., Mansfield C.M., Lehman J.J., Kovacs A., Courtois M., Saffitz J.E., et al. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 2004, 94:525-533.
17. Buerger A., Rozhitskaya O., Sherwood M.C., Dorfman A.L., Bisping E., Abel E.D., et al. Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 2006, 12:392-398.
18. Gropler M.C., Harris T.E., Hall A.M., Wolins N.E., Gross R.W., Han X., et al. Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J Biol Chem 2009, 284:6763-6772.
19. Lai L., Leone T.C., Zechner C., Schaeffer P.J., Kelly S.M., Flanagan D.P., et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev 2008, 22:1948-1961.
20. Chen Z., Gropler M.C., Norris J., Lawrence J.C., Harris T.E., Finck B.N. Alterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion. Arterioscler Thromb Vasc Biol 2008, 28:1738-1744.
21. Huss J.M., Kopp R.P., Kelly D.P. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem 2002, 277:40265-40274.
22. Zhang P., O'Loughlin L., Brindley D.N., Reue K. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J Lipid Res 2008, 49:1519-1528.
23. Li Y.L., Su X., Stahl P.D., Gross M.L. Quantification of diacylglycerol molecular species in biological samples by electrospray ionization mass spectrometry after one-step derivatization. Anal Chem 2007, 79:1569-1574.
24. Ogiso H., Suzuki T., Taguchi R. Development of a reverse-phase liquid chromatography electrospray ionization mass spectrometry method for lipidomics, improving detection of phosphatidic acid and phosphatidylserine. Anal Biochem 2008, 375:124-131.
25. Carman G.M., Lin Y.P. Phosphatidate phosphatase from yeast. Methods Enzymol 1991, 197:548-553.
26. Huss J.M., Imahashi K., Dufour C.R., Weinheimer C.J., Courtois M., Kovacs A., et al. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab 2007, 6:25-37.
27. van der Meer D.L., Degenhardt T., Vaisanen S., de Groot P.J., Heinaniemi M., de Vries S.C., et al. Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis. Nucleic Acids Res 2010, 38:2839-2850.
28. Bolotin E., Liao H., Ta T.C., Yang C., Hwang-Verslues W., Evans J.R., et al. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology 2010, 51:642-653.
29. Finck B.N., Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 2006, 116:615-622.
30. Huss J.M., Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ Res 2004, 95:568-578.
31. Lynn EG, Stevens MV, Wong RP, Carabenciov D, Jacobson J, Murphy E, et al. Transient upregulation of PGC-1alpha diminishes cardiac ischemia tolerance via upregulation of ANT1. J Mol Cell Cardiol 2010.
32. Miura S., Kawanaka K., Kai Y., Tamura M., Goto M., Shiuchi T., et al. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation. Endocrinology 2007, 148:3441-3448.
33. Garnier A., Fortin D., Delomenie C., Momken I., Veksler V., Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003, 551:491-501.
34. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A 2006, 103:10086-10091.
35. Alaynick W.A., Kondo R.P., Xie W., He W., Dufour C.R., Downes M., et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab 2007, 6:13-24.
36. Haemmerle G., Lass A., Zimmermann R., Gorkiewicz G., Meyer C., Rozman J., et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006, 312:734-737.
37. Banke N.H., Wende A.R., Leone T.C., O'Donnell J.M., Abel E.D., Kelly D.P., et al. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ Res 2010, 107:233-241.
38. Lehman J.J., Boudina S., Banke N.H., Sambandam N., Han X., Young D.M., et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol 2008, 295:H185-H196.
39. Fang Y., Vilella-Bach M., Bachmann R., Flanigan A., Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001, 294:1942-1945.
40. Nadra K., de Preux Charles A.S., Medard J.J., Hendriks W.T., Han G.S., Gres S., et al. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev 2008, 22:1647-1661.
41. Winter J.N., Fox T.E., Kester M., Jefferson L.S., Kimball S.R. Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway. Am J Physiol Cell Physiol 2010, 299:C335-C344.
42. Leone T.C., Weinheimer C.J., Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 1999, 96:7473-7478.
43. Finck B.N., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002, 109:121-130.